Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jean Li Yan"'
Autor:
Matthew Dryden, Michal Kantecki, Jean Li Yan, Gregory G. Stone, Heidi Leister-Tebbe, Mark Wilcox
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 28, Iss , Pp 108-114 (2022)
ABSTRACT: Objectives: This exploratory pooled analysis assessed the efficacy and safety of ceftaroline fosamil and comparators across six phase III clinical trials in adults with community-acquired pneumonia (CAP) or complicated skin and soft-tissue
Externí odkaz:
https://doaj.org/article/9b91dfa17c6e4c0f8d6a9988707d2d8a
Autor:
Miguel Sánchez-García, Jennifer Hammond, Jean Li Yan, Michal Kantecki, Wajeeha Ansari, Matthew Dryden
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 3, Pp 609-623 (2020)
Abstract Aim Exploratory analyses evaluated patient characteristics and outcomes among patients with complicated skin and soft tissue infection (cSSTI) in the phase 3 COVERS study who were admitted to an intensive care unit (ICU). Methods Adults with
Externí odkaz:
https://doaj.org/article/cfcc5b617cf54d3599cd3e2aae72096a
Autor:
Jie Jin, Depei Wu, Yang Liu, Sisi Pan, Jean Li Yan, Jalal A. Aram, Yin-jun Lou, Haitao Meng, Xiaochen Chen, Xian’an Zhang, Ilan S. Schwartz, Thomas F. Patterson
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Pulmonary computed tomography (CT) scans are commonly used as part of the clinical criteria in diagnostic workup of invasive fungal diseases like invasive aspergillosis, and may identify radiographic abnormalities, such as halo si
Externí odkaz:
https://doaj.org/article/bead5b81c75546579f6664863844555e
Autor:
Gregory G. Stone, Mark H. Wilcox, Jean Li Yan, Michal Kantecki, Pedro L Gonzalez, Matthew Dryden
Publikováno v:
Infectious Diseases and Therapy. 11:217-230
INTRODUCTION In three phase III randomized controlled trials, ceftaroline fosamil was shown to be non-inferior to vancomycin plus aztreonam for the treatment of complicated skin and soft tissue infections (cSSTIs). This exploratory analysis evaluated
Autor:
Lisa R. Hartman, Ildar Nurmeev, Pavel Svirin, Kevin D. Wolter, Jean Li Yan, Darshana Jani, Neil A. Goldenberg, Nancy Sherman
Publikováno v:
Pediatric Blood & Cancer. 69
Data from registrational trials of pediatric venous thromboembolism (VTE) treatment are sparse, especially among cancer patients. We conducted a prospective, multicenter, open-label trial (NCT00952380) on dose-finding, safety, and efficacy (measured
Autor:
Mark, Wilcox, Jean Li, Yan, Pedro L, Gonzalez, Matthew, Dryden, Gregory G, Stone, Michal, Kantecki
Publikováno v:
Infectious diseases and therapy. 11(1)
In three phase III randomized controlled trials, ceftaroline fosamil was shown to be non-inferior to vancomycin plus aztreonam for the treatment of complicated skin and soft tissue infections (cSSTIs). This exploratory analysis evaluated the impact o
Autor:
Sisi Pan, Yinjun Lou, Thomas F. Patterson, Xian’an Zhang, Jean Li Yan, Depei Wu, Jie Jin, Haitao Meng, Yang Liu, Jalal A. Aram, Ilan S. Schwartz, Xiaochen Chen
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases
BMC Infectious Diseases
Background Pulmonary computed tomography (CT) scans are commonly used as part of the clinical criteria in diagnostic workup of invasive fungal diseases like invasive aspergillosis, and may identify radiographic abnormalities, such as halo signs or ai
Publikováno v:
Journal of Antimicrobial Chemotherapy
Background The recommended adult dose of ceftaroline fosamil is 600 mg q12h by 1 h intravenous (iv) infusion for 5–14 days in complicated skin and soft tissue infection (cSSTI) and 5–7 days in community-acquired pneumonia (CAP). A dosage of 600 m
Autor:
Francesco Giuseppe De Rosa, Alessandro Busca, Maria Rita Capparella, Jean Li Yan, Jalal A. Aram
Publikováno v:
Clinical Drug Investigation
Background Solid tumors are a common predisposing factor for invasive candidiasis (IC) or candidemia due to IC. Objectives Post hoc analysis of patient-level efficacy and safety data from six studies of anidulafungin (with similar protocols/endpoints
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::555787d58983415d159bcffeef9e3230
http://hdl.handle.net/2318/1797729
http://hdl.handle.net/2318/1797729
Autor:
Todd Riccobene, Gregory G. Stone, John S. Bradley, Jean Li Yan, Susan Raber, Victoria M Hendrick, Heidi Leister-Tebbe, Veronica Mas Casullo, Phylinda L. S. Chan, Jennifer Hammond
Publikováno v:
The Pediatric infectious disease journal. 39(5)
With increasing antimicrobial resistance, antibiotic treatment options for neonatal late-onset sepsis (LOS) are becoming limited. Primary objective of this study was assessment of the safety of ceftaroline fosamil in LOS.Eligible neonates and very yo